Enteral Vancomycin as Primary Prophylaxis Against Clostridioides Difficile Infection in Critically Ill Patients

Clinical trial NCT07221370 · RECRUITING

Trial details

NCT number: NCT07221370
Sponsor: Riverside University Health System Medical Center
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Clostridium Difficile Infection Vancomycin Resistant Enterococci Infection

Start date: 2024-10-21
Primary completion: 2026-12-31
Enrollment: 176

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.